insights_auto
Why is OCEA down 60,00%?
Dive Deeperchevron_right
OCEA:OTCMKTS
Ocean Biomedical Inc
USDÂ 0,00020
arrow_downward
-60,00%(-0,00030) 1D
12 Okt., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OCEA...
Open
USDÂ 0,00
High
USDÂ 0,00
Low
USDÂ 0,00
Mkt. cap
32,07Â k
Avg. vol.
38,40Â k
Volume
59,85Â k
52-wk high
USDÂ 0,01
52-wk low
USDÂ 0,00
Beta
2,65
Shares outstanding
232,36Â m
No. of employees
7
Open
USDÂ 0,00
High
USDÂ 0,00
Low
USDÂ 0,00
Mkt. cap
32,07Â k
Avg. vol.
38,40Â k
Volume
59,85Â k
52-wk high
USDÂ 0,01
52-wk low
USDÂ 0,00
Beta
2,65
Shares outstanding
232,36Â m
No. of employees
7
News stories
From web sources and news partners
Simply Wall Street
·
5 minute gelede
3 AI Infrastructure Stocks Tied To China Compute Demand
Yahoo Finance
·
33 minute gelede
What Does VEON (NASDAQ:VEON) Satellite To Mobile Launch Mean For Bangladesh?
BeInCrypto
·
17 minute gelede
Citi Says S&P 500 Needs AI and Non-AI Stocks to Reach 8,100
Profile
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
About Ocean Biomedical Inc